Dosage Forms (Dosage Form)

Subscribe to Selected New Research on Dosage Forms

327 relevant articles (48 outcomes, 48 trials/studies) found for this Bio-Agent

Description: Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include CAPSULES; LINIMENTS; OINTMENTS; PHARMACEUTICAL SOLUTIONS; POWDERS; TABLETS; etc.

Also Known As:

Dosage Form; Form, Dosage; Forms, Dosage

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Kumar, Maansi G: 2 articles (01/2007 - 01/2007)
2.	Lin, Senshang: 2 articles (01/2007 - 01/2007)
3.	Sukhanov, S V: 1 article (11/2007)
4.	Mazo, E B: 1 article (11/2007)
5.	Ivanov, R V: 1 article (11/2007)
6.	Sereda, E G: 1 article (11/2007)
7.	Krivoborodov, G G: 1 article (11/2007)
8.	Korzenkova, L V: 1 article (07/2007)
9.	Lagutina, Iu M: 1 article (07/2007)
10.	Budzinskaia, M V: 1 article (07/2007)

Related Diseases

1.	Neoplasm Metastasis (Metastasis) 02/01/1993 - "From these results, it appears that the new dosage form of aclacinomycin A, ACR-CH, with superior therapeutic efficacy against lymph node metastases, can also enhance the immune response of regional lymph node cells. " 07/01/1991 - "A new dosage form (PEP-CH) of peplomycin was tested for therapeutic efficacy against lymph node metastasis in mice. " 09/01/1990 - "In view of the fact that activated carbon readily migrates to the lymph node, clinical application of this drug dosage form may be useful in cases of malignant tumor metastasis to the lymph node." 08/01/1992 - "[Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles]" 06/01/1992 - "Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles." Order ALL the reference details at left...
2.	Neoplasms (Cancer) 08/01/2004 - "These studies have laid the foundation for a "one-bullet" dosage form that may provide convenient and effective delivery of multiple drug treatment of tumors." 01/01/2007 - "The multiple-bead FDF was found to reduce the tumor incidence in mice by 74%, while the conventional tablet dosage form reduced this incidence by only 25%. " 03/01/2002 - "Efforts to further optimize therapeutic effectiveness through drug delivery strategies that prolong tumor exposure to these S phase-specific agents, such as improving oral bioavailability through structure modification and innovative formulation approaches, alternative parenteral dosage forms, and administration schedules, are being actively pursued. " 11/01/1987 - "The heterologous dosage forms (oleosu, ointment) were developed for exerting a long-lasting at local tumor sites. " 04/01/1987 - "The effect of a new dosage form for anti-cancer agents was studied on tissue distribution and compared with the aqueous solution form. " Order ALL the reference details at left...
3.	Postoperative Pain 03/01/2002 - "OBJECTIVE: To study the efficacy of piroxicam fast-dissolving dosage form in reducing postoperative pain after simple lumbar spine surgery. " 03/01/2002 - "The clinical efficacy of piroxicam fast-dissolving dosage form for postoperative pain control after simple lumbar spine surgery: a double-blinded randomized study." 01/01/2005 - "Bupivacaine lipid microparticles were prepared and evaluated as a parenteral sustained-release dosage form for postoperative pain management. " 04/01/2004 - "SUMMARY: Technical difficulties in analgesic drug administration, inappropriate prescribing, unfounded patient fears or expectations, and the lack of availability of parenteral dosage forms of certain analgesic agents can potentially contribute to inadequate postoperative pain control. " 03/01/2002 - "Because of its low side effects and high toleration, piroxicam fast-dissolving dosage form may be considered as an alternative for postoperative pain control during the early postoperative period." Order ALL the reference details at left...
4.	Pain (Aches) 01/01/1987 - "maintenance of the quality of life by complete or nearly complete pain remission in association with lack of abuse potential, oral dosage form and lack of disturbance of vital functions." 11/01/2008 - "It is believed that acute pain suppresses nervus vagus, thereby, influencing gastrointestinal secretion and motility, which are the two factors that are necessary for disintegration and dissolution of solid dosage forms. " 02/01/2008 - "In this article, currently commercialized and developing drug products for pain management are reviewed with respect to dosage form design as well as clinical efficacy. " 04/01/1998 - "Noticeable changes occurred in the selection of pain medicines and dosage forms, and in the increased number of home care instructions provided for parents. " 01/01/1998 - "CONCLUSION: New dosage forms of the enzyme preparations (pancitrate 25,000, in particular) are highly effective both in deficiency of pancreatic external secretion and pain relief in exacerbation of CP." Order ALL the reference details at left...
5.	Ulcerative Colitis 08/01/2004 - "CONCLUSION: Compared with the conventional delivery systems, drug release from the new dosage form may offer a new dimension for the oral treatment of mid to distal ulcerative colitis." 01/01/1999 - "The therapeutic effects of R68070 against ulcerative colitis were observed in both dosage forms in a dose dependent manner. " 01/01/1999 - "These results suggest that chitosan capsule might be a very useful dosage form for the colon-specific delivery of R68070 as an anti-inflammatory drug and for the therapy of ulcerative colitis." 04/01/1997 - "With the discovery of the potential relationship between nonsmoking status and the onset of ulcerative colitis and the development of various nicotine dosage forms came the hypothesis that nicotine may play a protective role against the development of ulcerative colitis and maintenance of remission. " 05/01/2001 - "The aim of the present study was to develop a multi-unit dosage form containing 5-aminosalicylic acid (5-ASA) for the treatment of ulcerative colitis (UC), optimised on the basis of recent studies indicating that UC patients have higher intestinal pH than was previously thought to be the case. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Tablets
2.	Aclarubicin
3.	Piroxicam (Feldene)
4.	Carbon
5.	Nicotine
6.	Rifampin (Rifampicin)
7.	Itraconazole (Sporanox)
8.	Mitomycin (Mitomycin-C)
9.	Cisplatin (Platino)
10.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Microspheres (Microsphere)
3.	Analgesia
4.	Transplants (Transplant)
5.	Thrombolytic Therapy

Best Treatments:
Research Summary Report
on Neoplasm Metastasis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3261 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>